India has over 5,000 Jan Aushadhi stores that cover a list of 800 plus drugs, both chronic and acute, across therapies like anti-cancer, anti-infective, reproductive and gastro intestinal medicines.
By 2020, the government is eyeing opening of another 2,500 stores.
Jan Aushadhi stores clocked aggregate sales of Rs 150 crore in second half of FY19, according to the Department of Pharmaceuticals (DoP).
BPPI posted around Rs 120 crore sales in FY18 at maximum retail price, which corresponds to approximately Rs 600 crore of branded products, versus Rs 33 crore in FY17 and Rs 12.4 crore in FY16.
"We believe this two-pronged focus will enable the BPPI to expand to over 10,000 stores by FY21. With each store achieving monthly sales of around Rs 5 lakh, the scheme is set to top Rs 6,000 crore by FY21," the report said.
It added that as unbranded generics and Jan Aushadhi gain steam, there will be further pressure on volume, leading to lower revenue growth for branded market.
It further said that branded revenue growth will become a challenge in the coming years as generics market share will keep on increasing.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.